Carla V. Rothlin, Ph.D. is the Dorys McConnell Duberg Professor of Immunobiology and Pharmacology at Yale School of Medicine, Co-Leader of Cancer Immunology Program at the Yale Cancer Center and HHMI Faculty Scholar. Dr. Rothlin studied Biochemistry and Pharmacy at the University of Buenos Aires, where she also performed her graduate studies under the direction of Dr. Ana Belen Elgoyhen on nicotinic receptors expressed in the inner ear. Following her Ph.D., Dr. Rothlin moved to San Diego, California and joined Dr. Greg Lemke's lab at the Salk Institute for Biological Studies. Dr. Rothlin was appointed as an Assistant Professor in Immunobiology at Yale School of Medicine in 2009. Dr. Rothlin’s research focuses on mechanisms that underlie the regulation of inflammation and the homeostatic control of immune function. Her laboratory has identified the function of the TAM receptor tyrosine kinases in the negative regulation of the immune response and resolution of inflammation. Dr. Rothlin’s contributions have been recognized by numerous foundations, such as the PEW Foundation and Howard Hughes Medical Institute. Dr. Rothlin is also highly committed to Yale’s education mission and was appointed Director of Graduate Studies in Immunobiology in 2018.
« Go Back